Feeds:
Posts
Comments

Posts Tagged ‘venture financing’

Here is an article I found at cleantech.

“San Francisco, Calif.-based CMEA Capital is on the hunt for the best and brightest cleantech investments. But if the investors can’t find what they are looking for, founder and Managing Director Tom Baruch told the Cleantech Group they’ll create their own company.

The venture capital firm usually invests anywhere from $10 million to $15 million per company, over the life of its involvement with the company, he said. And these days, renewable fuels and chemicals from cellulosic precursors as well as algae are catching the attention of CMEA investors. Baruch said they are working on a stealth project in collaboration with a university in San Diego to genetically modify algae to produce chemicals.

“We’re working to see if we can build our own company,” he said. “We’re shopping for the right technologies and supporting some small research projects.”

CMEA has also invested about $15 million to date in Codexis, which makes producing biofuels, pharmaceuticals and industrial products faster through its next-generation biocatalytic chemical manufacturing processes. CMEA was involved in spinning Codexis out of Redwood City, Calif.-based biotech company Maxygen (Nasdaq:MAXY).

Codexis, which filed its S-1 in 2008 (see Codexis files for $100M IPO) and then pulled it due to market conditions (see Codexis withdraws IPO), has attracted significant private equity investment with IPO plans on the horizon again come 2010.

In March, global energy giant Royal Dutch Shell NYSE:(RDS.A) and Codexis expanded an agreement to develop better biocatalysts, with Shell increasing its equity stake in Codexis. The companies first announced the partnership in 2006 to investigate other biofuels, researching new enzymes to convert biomass directly into components similar to gasoline and diesel, with Shell taking a stake in the company in 2007 (see Shell partners with Codexis for next generation biofuel research and Shell, Codexis in biofuels agreement).

Baruch said he expects Codexis to turn a profit by the end of this year.

“We want to be involved in companies that are truly transformative—that change the way people do things and think about things, that have cost and performance characteristics that are a leap apart from what’s currently available,” he said.  “And frankly, if it’s not transformative I don’t want to do it.”

To read the full article, click here.

Read Full Post »

Here is some good news posted at WSJ Venture dispatch. Please visit them for the whole article by clicking here.

“When chief information officers from across the country gathered Wednesday in Cambridge, Mass., for the sixth annual Massachusetts Institute of Technology Sloan CIO Symposium, talk was of virtualization and cloud computing, and the forecast was for a reconstruction of business IT infrastructure made more urgent by the economy’s troubles.

One panelist, MIT Professor Erik Brynjolfsson, even went so far as to say this period could become known in information technology lore as “the great restructuring.” He said it would have three elements, experimentation, measurement and building on scale.

Author James Champy, chairman of consulting at Perot Systems Corp., said many industries have overbuilt IT capacity and face a three-to-five-year challenge to right-size. He advised CIOs to reduce the cost basis of the enterprise to remove top line uncertainty across the business and to generate cash to invest in innovation.”

Read Full Post »

Here is a good article by Scott Austin at WSJ Online on a subject we brought up last week.

“Start-up companies appear to be giving into investor demands of a harsher funding deal term that gained notoriety after the tech bubble burst in the early part of the decade.

According to two separate quarterly reports issued last week from law firms Fenwick & West and Cooley Godward Kronish, venture capital firms are more frequently receiving multiple liquidation preferences that protect them from losing out on investments.

Venture capital firms almost always receive preferred stock when they invest in companies, giving them certain rights over common stock holders, usually the founders and executives. One of these standard rights is a liquidation preference, which gives preferred stock holders the right to get their money back from a company before other common stock holders in an unfavorable sale or liquidation.

But with more companies in trouble, investors are inserting multiple liquidation preferences into term sheets, meaning they could get two times or more the amount of capital they invested. That can create nightmarish capital structures for companies but give them more incentive for them to become successful.”

Read the full article here.

Read Full Post »

Here is a good article from WSJ online by Jonathan Matsey.

The Israeli life science industry was in the spotlight recently, when Medtronic Inc. agreed to pay $325 million up-front for Netanya-based Ventor Technologies Ltd., which had raised $17 million in venture financing in part from Pitango Venture Capital. While the deal was great for Ventor’s investors, Rafi Hofstein, chairman of Hadasit Bio-Holdings Ltd., a publicly traded tech-transfer company for Jerusalem’s Hadassah University Hospital, said it highlights a problem with the country’s life science industry: the inability to develop home-grown companies to fruition. And despite the global economic downturn and the re-location of many of the country’s drug and device companies overseas, Hofstein said government policy – and a possible $240 million public-sponsored biotech fund – may ultimately reignite Israel’s life science industry.

Read the full article here

Read Full Post »

The Valley’s latest extreme sport is feigning nonchalance about the economy. Living in an earthquake zone requires developing a habit of stoic flinchiness. The economy’s seismic shifts are slower, but just as unpredictable; all one can do it shrug one’s shoulders, stock the emergency kit, and keep on living. “We’re watching the economy crater all around us, but … well, we’re not really seeing any direct impact,” writes Tech Ticker anchor Sarah Lacy. “Making things more uneasy for those here in 2000: We didn’t cause this one.” Lacy’s right to reach back in history for examples, but her timing is off. This is 1998 all over again.

Read the whole article here

Read Full Post »

« Newer Posts - Older Posts »